Thrombosis is a hallmark of life-threatening diseases, such as myocardial infarction, stroke or venous thromboembolism representing major causes of death in the western civilization. In 2014 the Special Research Program SFB-F54 (“Cellular Mediators Linking Inflammation and Thrombosis”) was launched at the Medical University Vienna financed by the Austrian Science Fund (FWF), which comprises a network of eight research groups that are focusing on molecular and cellular links between inflammation and thrombotic diseases to provide a new view of thrombosis integrating the role of inflammatory processes thereby building up new strategies for therapeutic interventions.

Our Special Research Program SFB-F54 has been extended for a second funding phase from 2018 - 2022.


Events

 

Dr. Karin Hochrainer (Weill Cornell Medicine, NYC)

 

“From lipids to thrombosis: translational research targeting HDL and platelet function”

 

2018-09-28, 3.p.m.; Seminarroom E8, CeMM

 
 

News and recent publications

 
   

Ingrid Pabinger-Fasching

 
 

Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks

 
 

Disease models play a major role in Covid-19 research since they allow the study of disease mechanisms or the development of effective and safe vaccines and treatments. In the search for ever better tools, a research group led by Sylvia Knapp at..

 
 

Christoph Binder's group could show that APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans

 
 
 
 

Featured